Key SURMOUNT-5 findings UK patients should know Mounjaro produced 20.2% average weight loss vs Wegovys 13.7% in the same trial, at the same time, with the same population Nearly twice as many Mounjaro patients achieved 20%+ weight loss (31.6% vs 16.1%) Three times as many Mounjaro patients achieved 25%+ weight loss (15.4% vs 5.0%) indicating Mounjaros advantage is more pronounced at higher levels of weight loss Tolerability was comparable discontinuation rates due to adverse events were similar between the two medications The practical implication is clear: for patients where maximum weight loss is the primary goal and cost is not a barrier, SURMOUNT-5 provides strong evidence for choosing Mounjaro
One to try: Life Extension N-Acetyl-L-CysteineNAC (Buy on Life Extension, $16.50)
The evidence for divided dosing over single daily dosing is not established in humans
regulates gene expression and apoptosis, and is involved in the transmembrane transport of organic solutes
Focusing on muscle recovery, digestive health, and skin elasticity, Replenza aims to become a trusted partner for those navigating their GLP-1 journey
However, as with any surgical procedure, there are always risks and possible side effects to be aware of